$VEEV
VEEVA SYSTEMS INC

2021 Q2 Form 10-Q Financial Statement

#000139305221000028 Filed on June 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $433.6M $337.1M
YoY Change 28.62% 37.73%
Cost Of Revenue $116.1M $94.88M
YoY Change 22.4% 44.85%
Gross Profit $317.4M $242.2M
YoY Change 31.05% 35.13%
Gross Profit Margin 73.21% 71.85%
Selling, General & Admin $105.8M $92.42M
YoY Change 14.43% 46.46%
% of Gross Profit 33.32% 38.16%
Research & Development $83.23M $62.24M
YoY Change 33.72% 38.39%
% of Gross Profit 26.22% 25.69%
Depreciation & Amortization $2.000M $2.000M
YoY Change 0.0% 0.0%
% of Gross Profit 0.63% 0.83%
Operating Expenses $189.0M $154.7M
YoY Change 22.2% 43.1%
Operating Profit $128.4M $87.57M
YoY Change 46.69% 23.04%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $4.564M $3.414M
YoY Change 33.68% -44.59%
Pretax Income $133.0M $90.98M
YoY Change 46.2% 17.65%
Income Tax $17.44M $4.409M
% Of Pretax Income 13.11% 4.85%
Net Earnings $115.6M $86.57M
YoY Change 33.5% 17.86%
Net Earnings / Revenue 26.65% 25.68%
Basic Earnings Per Share $0.76 $0.58
Diluted Earnings Per Share $0.71 $0.54
COMMON SHARES
Basic Shares Outstanding 152.4M shares 149.5M shares
Diluted Shares Outstanding 162.2M shares 159.5M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.150B $1.381B
YoY Change 55.72% 3.86%
Cash & Equivalents $1.185B $720.8M
Short-Term Investments $965.5M $660.2M
Other Short-Term Assets $30.94M $21.10M
YoY Change 46.63% 1.44%
Inventory
Prepaid Expenses
Receivables $262.3M $235.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.495B $1.675B
YoY Change 48.93% 8.93%
LONG-TERM ASSETS
Property, Plant & Equipment $52.25M $52.89M
YoY Change -1.21% -25.3%
Goodwill $436.0M $439.0M
YoY Change -0.68%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.01M $15.73M
YoY Change 33.59% -67.7%
Total Long-Term Assets $727.1M $729.3M
YoY Change -0.31% 206.19%
TOTAL ASSETS
Total Short-Term Assets $2.495B $1.675B
Total Long-Term Assets $727.1M $729.3M
Total Assets $3.222B $2.405B
YoY Change 34.0% 35.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.86M $15.04M
YoY Change 25.38% 79.06%
Accrued Expenses $75.62M $59.50M
YoY Change 27.09% 69.03%
Deferred Revenue $608.7M $470.3M
YoY Change 29.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $96.00K $1.000M
YoY Change -90.4% 0.0%
Total Short-Term Liabilities $709.5M $550.3M
YoY Change 28.93% 33.39%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $100.0K
YoY Change -100.0% -90.91%
Other Long-Term Liabilities $12.46M $9.140M
YoY Change 36.31% 19.03%
Total Long-Term Liabilities $12.46M $9.140M
YoY Change 36.31% 19.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $709.5M $550.3M
Total Long-Term Liabilities $12.46M $9.140M
Total Liabilities $777.2M $603.6M
YoY Change 28.76% 36.87%
SHAREHOLDERS EQUITY
Retained Earnings $1.415B $1.006B
YoY Change 40.65% 45.41%
Common Stock $1.032B $792.7M
YoY Change 30.2% 23.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.445B $1.801B
YoY Change
Total Liabilities & Shareholders Equity $3.222B $2.405B
YoY Change 34.0% 35.39%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $115.6M $86.57M
YoY Change 33.5% 17.86%
Depreciation, Depletion And Amortization $2.000M $2.000M
YoY Change 0.0% 0.0%
Cash From Operating Activities $478.4M $282.2M
YoY Change 69.54% 19.42%
INVESTING ACTIVITIES
Capital Expenditures -$2.656M -$267.0K
YoY Change 894.76% -122.36%
Acquisitions
YoY Change
Other Investing Activities -$35.29M -$48.20M
YoY Change -26.78% 20.8%
Cash From Investing Activities -$37.95M -$48.21M
YoY Change -21.28% 16.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $16.81M $9.533M
YoY Change 76.28% 203.41%
NET CHANGE
Cash From Operating Activities $478.4M $282.2M
Cash From Investing Activities -$37.95M -$48.21M
Cash From Financing Activities $16.81M $9.533M
Net Change In Cash $454.5M $244.0M
YoY Change 86.23% 23.76%
FREE CASH FLOW
Cash From Operating Activities $478.4M $282.2M
Capital Expenditures -$2.656M -$267.0K
Free Cash Flow $481.0M $282.4M
YoY Change 70.32% 20.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001393052
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2020Q2 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
0 USD
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
veev:OperatingAndFinanceLeaseLiabilityCurrent
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-30
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-36121
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
Veeva Systems Inc.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8235463
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
4280 Hacienda Drive
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
358000 USD
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Pleasanton
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94588
CY2021Q2 dei City Area Code
CityAreaCode
925
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
452-6500
CY2021Q2 dei Security12b Title
Security12bTitle
Class A Common Stock,par value $0.00001 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
VEEV
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1184980000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
730504000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
965453000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
193000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
262327000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
564387000 USD
CY2021Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
51367000 USD
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
47206000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30939000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35607000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
2495066000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2310826000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52248000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD
CY2021Q2 us-gaap Deferred Costs
DeferredCosts
40007000 USD
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
42072000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53776000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56917000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
436029000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
436029000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
110166000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114595000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13845000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14100000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21012000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17878000 USD
CY2021Q2 us-gaap Assets
Assets
3222149000 USD
CY2021Q1 us-gaap Assets
Assets
3046067000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
18858000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23253000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31720000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30410000 USD
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
32716000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30982000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6299000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2590000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
608673000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
616992000 USD
CY2021Q2 veev Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
11280000 USD
CY2021Q1 veev Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
11725000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
709546000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
715952000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6488000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1835000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48672000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51393000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12459000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10567000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
777165000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
779747000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1032063000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
965670000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2304000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
992000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1415223000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1299656000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2444984000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2266320000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3222149000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3046067000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
433573000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
337106000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
116136000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94880000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
317437000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
242226000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
83226000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
62237000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
64610000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
55755000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41155000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36669000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
188991000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
154661000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
128446000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
87565000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4564000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3414000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133010000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
90979000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17443000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4409000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
115567000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
86570000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.58
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152444000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149541000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
162213000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159474000 shares
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1086000 USD
CY2020Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1297000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2213000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
389000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
112268000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
88256000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
48489000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36907000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
2266320000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17600000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
48793000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3296000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
115567000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2444984000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1665594000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10279000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36907000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1686000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
86570000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1801036000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
115567000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
86570000 USD
CY2021Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
6628000 USD
CY2020Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
7878000 USD
CY2021Q2 veev Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2827000 USD
CY2020Q2 veev Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2997000 USD
CY2021Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1542000 USD
CY2020Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
11000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
48489000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
36907000 USD
CY2021Q2 veev Amortization Of Deferred Costs Excluding Right Of Use Assets
AmortizationOfDeferredCostsExcludingRightOfUseAssets
6355000 USD
CY2020Q2 veev Amortization Of Deferred Costs Excluding Right Of Use Assets
AmortizationOfDeferredCostsExcludingRightOfUseAssets
4751000 USD
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5242000 USD
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1134000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-431000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-93000 USD
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
159000 USD
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-393000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-301732000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-154160000 USD
CY2021Q2 veev Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
4161000 USD
CY2020Q2 veev Increase Decrease In Unbilled Accounts Receivable
IncreaseDecreaseInUnbilledAccountsReceivable
4452000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
4290000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
3342000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3709000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1850000 USD
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2737000 USD
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-551000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6794000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4430000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6967000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2691000 USD
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-8176000 USD
CY2020Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1477000 USD
CY2021Q2 veev Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-2748000 USD
CY2020Q2 veev Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-2811000 USD
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2169000 USD
CY2020Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2520000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
478385000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
282172000 USD
CY2021Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
256938000 USD
CY2020Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
188818000 USD
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
221645000 USD
CY2020Q2 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
140342000 USD
CY2021Q2 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
2656000 USD
CY2020Q2 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-267000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37949000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48209000 USD
CY2021Q2 veev Finance Lease Proceeds Payments Net
FinanceLeaseProceedsPaymentsNet
-286000 USD
CY2020Q2 veev Finance Lease Proceeds Payments Net
FinanceLeaseProceedsPaymentsNet
-248000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17091000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9781000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16805000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9533000 USD
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2765000 USD
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
548000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
454476000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
244044000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
731712000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
479797000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1186188000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
723841000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1184980000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
720776000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1208000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3065000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1186188000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
723841000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5133000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5866000 USD
CY2021Q2 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
17451000 USD
CY2020Q2 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
19615000 USD
CY2021Q2 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
806000 USD
CY2020Q2 veev Increase Decrease In Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInCapitalExpendituresIncurredButNotYetPaid
590000 USD
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the condensed consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the determination of the period of benefit for amortization of deferred costs;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.5pt">the fair value of our stock-based awards.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As future events cannot be determined with precision, actual results could differ significantly from those estimates.</span></div>
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
963023000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2710000 USD
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
280000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
965453000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
929273000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3879000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
356853000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
428155000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
608600000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
504967000 USD
CY2021Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
965453000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
933122000 USD
CY2021Q2 us-gaap Deferred Costs
DeferredCosts
40000000 USD
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
42000000 USD
CY2021Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
6000000 USD
CY2020Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
5000000 USD
CY2020Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
110166000 USD
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
82860000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83266000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30612000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29616000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52248000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
2000000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
2000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
436000000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
436000000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
171176000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
61010000 USD
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
171176000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
56581000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
114595000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4000000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
13734000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
18163000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
18160000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
17417000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
13166000 USD
CY2021Q2 veev Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
29526000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
110166000 USD
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6217000 USD
CY2021Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
7498000 USD
CY2021Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4616000 USD
CY2021Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4134000 USD
CY2021Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
6050000 USD
CY2021Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4716000 USD
CY2021Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
10128000 USD
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
10250000 USD
CY2021Q2 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
4709000 USD
CY2021Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
3812000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31720000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30410000 USD
CY2021Q2 veev Accrued Fees Current
AccruedFeesCurrent
6533000 USD
CY2021Q1 veev Accrued Fees Current
AccruedFeesCurrent
6381000 USD
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
11420000 USD
CY2021Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
13598000 USD
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1631000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1515000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13132000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
9488000 USD
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
32716000 USD
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30982000 USD
CY2021Q2 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
1000000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.131
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2021Q2 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
17000000 USD
CY2020Q2 veev Excess Tax Benefit From Employee Stock Plans
ExcessTaxBenefitFromEmployeeStockPlans
20000000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
3000000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
3000000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3303000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2563000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
243000 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
306000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53776000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
56917000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11184000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11347000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48672000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51393000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
59856000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
62740000 USD
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y7M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9632000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11410000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10641000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7852000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6916000 USD
CY2021Q2 veev Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
21606000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
68057000 USD
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8201000 USD
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
59856000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12761289 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.48
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2794000000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1007790 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
276.50
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
485037 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
36.29
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
105892 shares
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
132.55
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
13178150 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.41
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2742000000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7195626 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
27.77
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
337106000 USD
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1833000000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
13178150 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
74.41
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2742000000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
300100000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
114600000 USD
CY2021Q2 veev Number Of Product Areas
NumberOfProductAreas
2 industry
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
348495 shares
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2386498 shares
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
433573000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
433573000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
337106000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52248000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
53650000 USD

Files In Submission

Name View Source Status
0001393052-21-000028-index-headers.html Edgar Link pending
0001393052-21-000028-index.html Edgar Link pending
0001393052-21-000028.txt Edgar Link pending
0001393052-21-000028-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
veev-20210430.htm Edgar Link pending
veev-20210430.xsd Edgar Link pending
veev-20210430xexx311.htm Edgar Link pending
veev-20210430xexx312.htm Edgar Link pending
veev-20210430xexx321.htm Edgar Link pending
veev-20210430xexx322.htm Edgar Link pending
veev-20210430_cal.xml Edgar Link unprocessable
veev-20210430_def.xml Edgar Link unprocessable
veev-20210430_g1.jpg Edgar Link pending
veev-20210430_htm.xml Edgar Link completed
veev-20210430_lab.xml Edgar Link unprocessable
veev-20210430_pre.xml Edgar Link unprocessable